1. Home
  2. SLQT vs MLYS Comparison

SLQT vs MLYS Comparison

Compare SLQT & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

SELL

Current Price

$0.36

Market Cap

72.4M

Sector

Finance

ML Signal

SELL

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

SELL

Current Price

$21.38

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SLQT
MLYS
Founded
1985
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
1.9B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
SLQT
MLYS
Price
$0.36
$21.38
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$2.09
★ $46.33
AVG Volume (30 Days)
1.2M
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.43
EPS
★ N/A
N/A
Revenue
★ $1,618,499,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.88
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 6.02
N/A
52 Week Low
$0.30
$20.12
52 Week High
$2.17
$47.65

Technical Indicators

Market Signals
Indicator
SLQT
MLYS
Relative Strength Index (RSI) 46.74 40.97
Support Level N/A $20.12
Resistance Level $0.78 $22.24
Average True Range (ATR) 0.02 1.19
MACD 0.01 0.14
Stochastic Oscillator 94.17 30.34

Price Performance

Historical Comparison
SLQT
MLYS

About SLQT SelectQuote Inc.

SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: